...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Successful S-1 monotherapy for chemorefractory thymic carcinoma.
【24h】

Successful S-1 monotherapy for chemorefractory thymic carcinoma.

机译:化学治疗难治性胸腺癌的成功S-1单一疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

The optimal chemotherapeutic regimen for inoperable thymic carcinoma remains uncertain and little information is available regarding the usefulness of salvage chemotherapy. S-1, a newly developed oral fluorouracil antitumor drug, has been reported to be effective in the treatment of gastrointestinal tumors and non-small cell lung cancer. This case study reports a case of chemorefractory thymic cancer with a good response to S-1 monotherapy. S-1 was used as sixth-line chemotherapy and the response was the first remarkable tumor regression in the patient's clinical course. S-1 appears to have significant activity against thymic carcinoma.
机译:无法手术的胸腺癌的最佳化疗方案仍然不确定,关于挽救性化疗的有效性的信息很少。据报道,新开发的口服氟尿嘧啶抗肿瘤药物S-1可有效治疗胃肠道肿瘤和非小细胞肺癌。该案例研究报告了一例化学难治性胸腺癌,对S-1单一疗法反应良好。 S-1被用作六线化疗,其反应是该患者临床过程中首例明显的肿瘤消退。 S-1似乎对胸腺癌具有显着的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号